Ignite Creation Date:
2025-12-25 @ 12:32 AM
Ignite Modification Date:
2026-01-01 @ 4:09 AM
Study NCT ID:
NCT06049667
Status:
RECRUITING
Last Update Posted:
2023-09-22
First Post:
2023-09-11
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase 1 Clinical Trail of NTQ2494 Tablets in Patients With Advanced Hematological Malignancies
Sponsor:
Nanjing Chia-tai Tianqing Pharmaceutical
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Relapsed/Refractory Acute Myeloid Leukemia (AML) | View |
Keywords: